RYRAX (RYRAX) Stock Price & Analysis
RYRAX (RYRAX) fell 1.53% to USD 51.65 as of September 9, 2026 at 08:29 UTC, according to Nexqual real-time market data.
RYRAX last closed at USD 52.45; the session ranged USD 51.65–51.65 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.65–56.17 (NAS). Source: Nexqual, September 9, 2026 at 08:29 UTC.
Key Statistics (as of September 9, 2026 at 08:29 UTC)
| Price | USD 51.65 |
|---|---|
| Change | ▼ 1.53% (down) |
| Previous Close | USD 52.45 |
| Open | USD 51.65 |
| Day Range | USD 51.65 – 51.65 |
| 52-Week Range | USD 48.65 – 56.17 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYRAX)
Nexqual's technical model rates RYRAX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 08:29 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.83 (neutral) |
| vs SMA50 | Below (USD 52.86) |
| MACD | -0.36 (negative) |
Financial Health Score (RYRAX)
Nexqual rates RYRAX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 08:29 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYHAX | Rydex Series Fds, Health Care F | USD 128.57 | ▼ 3.11% |
| RYFAX | Rydex Series Fds, Financial Ser | USD 96.47 | ▼ 2.14% |
| RYKAX | Rydex Series Fds, Banking Fund | USD 116.55 | ▼ 1.26% |
| RYTAX | Rydex Series Fds, Technology Fu | USD 294.03 | ▲ 0.3% |
| RYMAX | Rydex Series Fds, Telecommunica | USD 74.23 | ▲ 1.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 08:29 UTC. This page is informational and not investment advice.